A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

NCT06049017 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Colitis, Ulcerative

Interventions

DRUG: JNJ-77242113
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC